Chemokines in rheumatic diseases

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, polymyositis /dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

Original languageEnglish
Pages (from-to)91-102
Number of pages12
JournalCurrent Drug Targets
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Rheumatic Diseases
Chemokines
Chemokine Receptors
Mixed Connective Tissue Disease
Systemic Vasculitis
Dermatomyositis
Antiphospholipid Syndrome
Synovial Membrane
Systemic Scleroderma
Systemic Lupus Erythematosus
Arthritis
Rheumatoid Arthritis
Leukocytes
Tissue

Keywords

  • Biological therapy
  • Chemokine receptors
  • Chemokines
  • Rheumatic diseases
  • Rheumatoid arthritis
  • Synovial tissue

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Chemokines in rheumatic diseases. / Szekanecz, Z.; Szűcs, G.; Szántó, S.; Koch, Alisa E.

In: Current Drug Targets, Vol. 7, No. 1, 01.2006, p. 91-102.

Research output: Contribution to journalArticle

@article{4c30bcb3bda34c419ec27591c61477ad,
title = "Chemokines in rheumatic diseases",
abstract = "Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sj{\"o}gren's syndrome, mixed connective tissue disease, polymyositis /dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.",
keywords = "Biological therapy, Chemokine receptors, Chemokines, Rheumatic diseases, Rheumatoid arthritis, Synovial tissue",
author = "Z. Szekanecz and G. Szűcs and S. Sz{\'a}nt{\'o} and Koch, {Alisa E.}",
year = "2006",
month = "1",
doi = "10.2174/138945006775270231",
language = "English",
volume = "7",
pages = "91--102",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Chemokines in rheumatic diseases

AU - Szekanecz, Z.

AU - Szűcs, G.

AU - Szántó, S.

AU - Koch, Alisa E.

PY - 2006/1

Y1 - 2006/1

N2 - Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, polymyositis /dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

AB - Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, polymyositis /dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

KW - Biological therapy

KW - Chemokine receptors

KW - Chemokines

KW - Rheumatic diseases

KW - Rheumatoid arthritis

KW - Synovial tissue

UR - http://www.scopus.com/inward/record.url?scp=33644922034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644922034&partnerID=8YFLogxK

U2 - 10.2174/138945006775270231

DO - 10.2174/138945006775270231

M3 - Article

C2 - 16454702

AN - SCOPUS:33644922034

VL - 7

SP - 91

EP - 102

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 1

ER -